Skip to main content
OpenTrials
Completed

NCT Number: NCT01519570

Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates

Despite the significant benefits of herpes zoster vaccine (HZV), vaccination rates remain low. Electronic medical records (EMR) can serve as a practical strategy to better facilitate the application of preventative health care, such as increasing immunization rates. A new care model that can increase the herpes zoster vaccination rate, as well as other preventative health services, is warranted. The objective of this study is to investigate if the functions of an EMR, in combination with a pharmacist as part of the care team, can improve the herpes zoster vaccination rate.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Herpes Zoster Disease Chickenpox DNA Virus Infections Herpesviridae Infections Infections Varicella Zoster Virus Infection Virus Diseases

Age range

60 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Ohio State University Martha Morehouse General Internal Medicine Clinic

Columbus, Ohio, 43221, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Greater than 60 years of age

Exclusion criteria

  • Documented herpes zoster vaccine in the EMR

Treatment and study plan

An informational packet regarding shingles and the HZV was sent to patients identified by the EMR

Other

The EMR generated a list of patients aged 60 or older without HZV documentation. Patients were categorized into two subgroups based on activated electronic patient portal (EPP) status. Randomized patients from each subgroup received an informational packet regarding shingles and the HZV by either the EMR or USPS mail, depending on EPP status. A pharmacist reviewed the medical chart of interested patients to assess if the HZV was clinically indicated; eligible patients were mailed a HZV prescription.

Primary outcomes

  1. Number of Participants Who Received the Herpes Zoster Vaccine

    Time frame: 6 months

    Six months after the intervention, a second EMR report was generated to determine the change in vaccination rate of both the intervention and control groups.

Secondary outcomes

  1. Difference in Vaccination Rates Between Patients Who Recieved a Mailed Letter Versus a Secure Email

    Time frame: 6 months

    Difference in vaccination rates between patients sent communications via US postal service (USPS) and those sent communications via electronic patient portal (EPP)

  2. Amount of Time Required by a Clinical Pharmacist to Manage This Workflow

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Ohio State University

Other

Registry information

Official study title

Use of an Electronic Medical Record to Improve Standard Practice in the Primary Care Setting: A Randomized-Controlled Study of Herpes Zoster Vaccination Rates

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Jan 27, 2012
Registry last updated
Feb 1, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.